Immediate Impact

1 by Nobel laureates 1 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
2023 Standout
Lung cancer
2021 Standout

Works of Steven Kaplan being referenced

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
1997

Author Peers

Author Last Decade Papers Cites
Steven Kaplan 239 62 35 602 365 22 756
Miao-Fen Chen 165 221 12 435 300 18 958
Vamsi Parimi 233 181 17 271 367 38 883
J. Herod 45 172 7 378 269 23 894
Jean Pierre Delord 183 83 8 501 226 20 769
C. Christodoulou 301 59 11 478 100 22 776
Deanna McLeod 226 67 15 453 218 25 771
Mary Cunningham 105 273 19 161 160 26 784
Hugo Prazeres 107 158 15 196 333 30 758
Florian Ewald 71 104 17 223 487 25 781
Xian Liu 225 76 6 287 378 25 804

All Works

Loading papers...

Rankless by CCL
2026